HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effects of Mannheimia haemolytica and albendazole on marbofloxacin pharmacokinetics in lambs.

Abstract
The study aimed to define the effects of M. haemolytica and a single oral dose of albendazole on the single-dose pharmacokinetics of marbofloxacin in lambs. The pharmacokinetic-pharmacodynamic integration of marbofloxacin was applied to describe a 3 mg/kg intramuscular dose in lambs. The 6 healthy and 12 naturally infected with M. haemolytica lambs (Akkaraman, males weighing 10-15 kg and aged 2-3 months) were used in this study. In the marbofloxacin group, 6 healthy lambs received marbofloxacin. In the albendazole group after 2 weeks washout period, the same animals received marbofloxacin on 1 h after albendazole. In the diseased marbofloxacin group, 6 lambs naturally infected with M. haemolytica received marbofloxacin. In the diseased albendazole group, 6 lambs naturally infected with M. haemolytica received marbofloxacin on 1 h after albendazole. The marbofloxacin and albendazole were administered each as a single dose of 3 mg/kg intramuscular and 7.5 mg/kg oral, respectively, in the respective groups. Plasma concentration of marbofloxacin was measured with HPLC-UV and pharmacokinetic parameters were analyzed by non-compartmental model. Albendazole did not change the pharmacokinetic profiles of marbofloxacin in healthy and diseased lambs. However, M. haemolytica affected the pharmacokinetics of marbofloxacin in diseased lambs, AUC0-24/MIC90 ratio was not found to be higher than 125, but Cmax/MIC90 ratios was found to be higher than 10 for an MIC value of 0.25 μg/mL in all groups. The marbofloxacin dose described in this study may not be effective for the treatment of infections due to M. haemolytica in lambs, with MIC ≤ 0.25 μg/mL.
AuthorsFeray Altan, Duygu Neval Sayin Ipek, Orhan Corum, Simten Yesilmen Alp, Polat Ipek, Kamil Uney
JournalTropical animal health and production (Trop Anim Health Prod) Vol. 51 Issue 8 Pg. 2603-2610 (Nov 2019) ISSN: 1573-7438 [Electronic] United States
PMID31230255 (Publication Type: Journal Article)
Chemical References
  • Anthelmintics
  • Anti-Bacterial Agents
  • Fluoroquinolones
  • marbofloxacin
  • Albendazole
Topics
  • Albendazole (pharmacology)
  • Animals
  • Anthelmintics (pharmacology)
  • Anti-Bacterial Agents (pharmacokinetics)
  • Fluoroquinolones (pharmacokinetics)
  • Injections, Intramuscular (veterinary)
  • Male
  • Mannheimia haemolytica (physiology)
  • Pasteurellosis, Pneumonic (drug therapy, microbiology)
  • Sheep
  • Sheep Diseases (drug therapy, microbiology)
  • Turkey

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: